Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples